Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial

Author: Gibson C.   Zorkun Cafer   Molhoek Peter   Żmudka Krzysztof   Greenberg Mark   Mueller Hiltrud   Wesdorp Jan   Louwerenburg Hans   Niederman Alan   Westenburg Jaap   Bikkina Mahesh   Batty John   Winter Jobst   Murphy Sabina   McCabe Carolyn  

Publisher: Springer Publishing Company

ISSN: 0929-5305

Source: Journal of Thrombosis and Thrombolysis, Vol.22, Iss.1, 2006-08, pp. : 13-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content